1: Meet Savvas Neophytou
MP3•Episode home
Manage episode 317769844 series 3305030
Content provided by Deepbridge Capital Discovery Podcast and Deepbridge Capital. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Deepbridge Capital Discovery Podcast and Deepbridge Capital or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Celebrating the launch of the Deepbridge Discovery Podcast, today we are joined by Savvas Neophytou (Partner & Head of Life Sciences - Deepbridge Capital) to discuss all things Deepbridge, his education and experience in the finance sector and get to know a little more about what Savvas likes doing in his spare time away from the office.
Supporting growth-focused companies and entrepreneurs has never been more important, but it is important to understand the people and ideas behind such investment opportunities.
Join the Deepbridge Capital team each week as they discuss all things Deepbridge, speak with various investment experts within the company and discover more about the founders and CEOs’ running the portfolio companies Deepbridge invests in. Each episode contains an informal conversation to understand how these leaders and teams perform in order to achieve their goals. Investments in early-stage companies are illiquid and high risk – investors could lose all of their capital.
Supporting growth-focused companies and entrepreneurs has never been more important, but it is important to understand the people and ideas behind such investment opportunities.
Join the Deepbridge Capital team each week as they discuss all things Deepbridge, speak with various investment experts within the company and discover more about the founders and CEOs’ running the portfolio companies Deepbridge invests in. Each episode contains an informal conversation to understand how these leaders and teams perform in order to achieve their goals. Investments in early-stage companies are illiquid and high risk – investors could lose all of their capital.
47 episodes